| 1 |
34606472 | Significance of CD8+ T cell infiltration-related biomarkers and the corresponding prediction model for the prognosis of kidney renal clear cell carcinoma. | 2021 Oct 4 |
1 |
| 2 |
30142009 | Prior exposure of pancreatic tumors to [sorafenib + vorinostat] enhances the efficacy of an anti-PD-1 antibody. | 2019 |
1 |
| 3 |
31295151 | Immunologic Features of Patients With Advanced Hepatocellular Carcinoma Before and During Sorafenib or Anti-programmed Death-1/Programmed Death-L1 Treatment. | 2019 Jul |
1 |
| 4 |
31391334 | Augmentation of IFN-γ+ CD8+ T cell responses correlates with survival of HCC patients on sorafenib therapy. | 2019 Aug 8 |
2 |
| 5 |
29304116 | The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow. | 2018 |
1 |
| 6 |
29431743 | Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. | 2018 Mar |
3 |
| 7 |
30521628 | Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow. | 2018 |
1 |
| 8 |
28754304 | A Natural CCR2 Antagonist Relieves Tumor-associated Macrophage-mediated Immunosuppression to Produce a Therapeutic Effect for Liver Cancer. | 2017 Aug |
1 |
| 9 |
23625925 | Reduced immunosuppressive properties of axitinib in comparison with other tyrosine kinase inhibitors. | 2013 Jun 7 |
1 |